• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[瘤内注射OK-432治疗乳腺癌的临床研究——局部注射部位的抗肿瘤免疫反应]

[Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].

作者信息

Hosokawa T

机构信息

Department of Surgery, Tokyo Women's Medical College, Daini Hospital, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 1991 May;92(5):577-86.

PMID:1831533
Abstract

To elucidate the mechanism of tumor reduction and local immune response after administration of OK-432 into the lesions of breast cancer, patients were given intratumoral injection of OK-432 before surgery. And precise identification of infiltrative lymphocytes was performed. The subjects were 25 patients with primary breast cancer. These patients were randomly divided into the following 3 groups: 10 patients given intratumoral injection of OK-432, 5 patients given intratumoral injection of physiological saline and 10 patients give no treatment. After operation frozen specimens of each tumor were subjected to simple immunohistochemical staining with Leu 2a, Leu 3a and Leu 7, and to immunohistochemical double staining with combination of Leu 2a x Leu 15 and Leu 3a x Leu-DR. Examination of infiltrative lymphocytes in the tumor revealed the positive rate was 100% for Leu 2a + cells (strongly positive, 70%), 90% for Leu 3a + cells (strongly positive, 70%) and 90% for Leu 7 + cells (strongly positive, 0%) in patients given intratumoral injection of OK-432. Double staining showed cytotoxic T cells and helper T cells were predominant among Leu 2a + cells and Leu3a + cells, respectively. Cytotoxic T cells, helper T cells and NK cells were induced at the tumor site after intratumoral injection of OK-432, suggesting the antitumor immune response of these cells is involved in tumor reduction following local administration of OK-432.

摘要

为阐明将OK-432注射到乳腺癌病灶后肿瘤缩小及局部免疫反应的机制,在手术前对患者进行瘤内注射OK-432,并对浸润淋巴细胞进行精确鉴定。研究对象为25例原发性乳腺癌患者。这些患者被随机分为以下3组:10例接受瘤内注射OK-432,5例接受瘤内注射生理盐水,10例不接受治疗。术后,对每个肿瘤的冰冻标本进行Leu 2a、Leu 3a和Leu 7的简单免疫组化染色,以及Leu 2a×Leu 15和Leu 3a×Leu-DR组合的免疫组化双重染色。肿瘤浸润淋巴细胞检查显示,瘤内注射OK-432的患者中,Leu 2a +细胞阳性率为100%(强阳性占70%),Leu 3a +细胞阳性率为90%(强阳性占70%),Leu 7 +细胞阳性率为90%(强阳性占0%)。双重染色显示,Leu 2a +细胞和Leu3a +细胞中分别以细胞毒性T细胞和辅助性T细胞为主。瘤内注射OK-432后,肿瘤部位诱导出细胞毒性T细胞、辅助性T细胞和NK细胞,提示这些细胞的抗肿瘤免疫反应参与了局部注射OK-432后的肿瘤缩小过程。

相似文献

1
[Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].[瘤内注射OK-432治疗乳腺癌的临床研究——局部注射部位的抗肿瘤免疫反应]
Nihon Geka Gakkai Zasshi. 1991 May;92(5):577-86.
2
[Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].接受化疗的癌症患者外周血淋巴细胞和肿瘤浸润淋巴细胞亚群
Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):482-8.
3
[Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
No To Shinkei. 1988 Jul;40(7):609-15.
4
[A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Gan To Kagaku Ryoho. 1988 Jun;15(6):1978-80.
5
[Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].[使用干扰素的多学科治疗及胶质瘤患者的免疫学评估:T细胞亚群的双色分析]
No Shinkei Geka. 1991 Feb;19(2):121-8.
6
[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].[环磷酰胺、大剂量溶链菌制剂与重组白细胞介素-2序贯免疫疗法对伴有弥漫性转移性肝肿瘤的乳腺癌患者的治疗效果改善]
Nihon Geka Gakkai Zasshi. 1991 Jan;92(1):64-74.
7
[Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].[瘤内注射OK-432后胃癌区域淋巴结淋巴细胞细胞毒性增强]
Nihon Geka Gakkai Zasshi. 1990 Jan;91(1):68-76.
8
[Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].[关于局部应用OK-432增强宫颈癌患者抗肿瘤活性的研究]
Gan To Kagaku Ryoho. 1986 Dec;13(12):3427-31.
9
[Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
No To Shinkei. 1995 May;47(5):466-73.
10
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].[通过免疫学参数评估OK-432(沙培林)口服给药的最佳剂量及其频率的双盲研究(第1份报告)]
Nihon Gan Chiryo Gakkai Shi. 1990 Apr 20;25(4):799-811.